AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹920 Cr | ₹816 Cr | ₹588 Cr | ₹713 Cr | ₹654 Cr |
What is the latest Consolidated Net Profit of AJANTA PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹920 Cr |
| Mar2025 | ₹816 Cr |
| Mar2024 | ₹588 Cr |
| Mar2023 | ₹713 Cr |
| Mar2022 | ₹654 Cr |
How is Consolidated Net Profit of AJANTA PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹920 Cr | 12.77 | |
| Mar2025 | ₹816 Cr | 38.81 | |
| Mar2024 | ₹588 Cr | -17.50 | |
| Mar2023 | ₹713 Cr | 8.99 | |
| Mar2022 | ₹654 Cr | - | |
Compare Consolidated Net Profit of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹44,249.4 Cr | 0.8% | -2.1% | 35.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 0.8% |
-2.1% |
35.9% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses